Soares, H. P., Crawford, S., Tesfaye, A. A., Nakasato, A., Multani, J., Wang, E. J., Patel, J., Chauhan, A. (2026). Clinical outcomes of [
177
Lu]Lu-DOTA-TATE (
177
Lu-DOTATATE) vs everolimus (EVE) in managing patients (pts) with gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): Real-world analysis of the PRIME initiative.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16316